Utility of gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage in premenopausal women with breast cancer: a systematic review and meta-analysis

References

• JemalASiegelRXuJWardECancer statistics, 2010CA Cancer J Clin201060527730020610543
   PubMed Web of Science ®Google Scholar
• AndersCKJohnsonRLittonJPhillipsMBleyerABreast cancer before age 40 yearsSemin Oncol200936323724919460581
   PubMed Web of Science ®Google Scholar
• KeeganTHDeRouenMCPressDJKurianAWClarkeCAOccurrence of breast cancer subtypes in adolescent and young adult womenBreast Cancer Res2012142R5522452927
   PubMed Web of Science ®Google Scholar
• AndersCKHsuDSBroadwaterGYoung age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expressionJ Clin Oncol200826203324333018612148
   PubMed Web of Science ®Google Scholar
• ClarkeMCoatesASDarbySCAdjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trialsLancet20083719606294018177773
   PubMed Web of Science ®Google Scholar
• WalsheJMDenduluriNSwainSMAmenorrhea in premenopausal women after adjuvant chemotherapy for breast cancerJ Clin Oncol200624365769577917130515
   PubMed Web of Science ®Google Scholar
• GoodwinPJEnnisMPritchardKIAdjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosisJ Clin Oncol199917112012910458225
   PubMed Web of Science ®Google Scholar
• SonmezerMOktayKFertility preservation in female patientsHum Reprod Update200410325126615140872
   PubMed Web of Science ®Google Scholar
• SchoverLRPremature ovarian failure and its consequences: vasomotor symptoms, sexuality, and fertilityJ Clin Oncol200826575375818258983
   PubMed Web of Science ®Google Scholar
• RecchiaFSicaGDe FilippisSSaggioGRosselliMReaSGoserelin as ovarian protection in the adjuvant treatment of premenopausal breast cancer: a phase II pilot studyAnti-Cancer Drugs200213441742411984088
   PubMed Web of Science ®Google Scholar
• AtayaKRamahi-AtayaAReproductive performance of female rats treated with cyclophosphamide and/or LHRH agonistReprod Toxicol1993732292358318754
   PubMed Web of Science ®Google Scholar
• BokserLSzendeBSchallyAVProtective effects of D-Trp6-luteinising hormone-releasing hormone microcapsules against cyclophosphamide-induced gonadotoxicity in female ratsBr J Cancer19906168618652142603
   PubMed Web of Science ®Google Scholar
• UrruticoecheaAArnedosMWalshGDowsettMSmithIEOvarian protection with goserelin during adjuvant chemotherapy for pre-menopausal women with early breast cancer (EBC)Breast Cancer Res Treat2008110341141617851753
   PubMed Web of Science ®Google Scholar
• WongMO’NeillSWalshGSmithIEGoserelin with chemotherapy to preserve ovarian function in pre-menopausal women with early breast cancer: menstruation and pregnancy outcomesAnn Oncol201324113313823019276
   PubMed Web of Science ®Google Scholar
• MaisanoRCaristiNMareMProtective effect of leuprolide on ovarian function in young women treated with adjuvant chemotherapy for early breast cancer: a multicenter phase II studyJ Chemother200820674074319129073
   PubMed Web of Science ®Google Scholar
• RecchiaFSaggioGAmiconiGGonadotropin-releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinomaCancer2006106351452316388519
   PubMed Web of Science ®Google Scholar
• ParkHJKooYAImYHYoonBKChoiDGnRH agonist therapy to protect ovarian function in young Korean breast cancer patientsJ Korean Med Sci201025111011620054409
   PubMed Web of Science ®Google Scholar
• JiangFYZhangQQZengJProtective effect of GnRHa on chemotherapy induced ovarian damage in breast cancer patientsShandong Med J20135381618
   Google Scholar
• LiMYHuangHLiangYTanJMLinDREffect of zoladex administered before chemotherapy on menstruation of patients with breast cancerChin J Oncol20083516905907
   Google Scholar
• SunJBJiangBYangLLiWQRenYHEffect of the goserelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancerJ Qiqihar Univ Med2014352224225
   Google Scholar
• SverrisdottirANystedtMJohanssonHFornanderTAdjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trialBreast Cancer Res Treat2009117356156719153828
   PubMed Web of Science ®Google Scholar
• BadawyAElnasharAEl-AshryMShahatMGonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized studyFertil Steril200991369469718675959
   PubMed Web of Science ®Google Scholar
• ElgindyEAEl-HaiegDOKhorshidOMGonadatrophin suppression to prevent chemotherapy-induced ovarian damage: a randomized controlled trialObstet Gynecol20131211788623262931
   PubMed Web of Science ®Google Scholar
• MooreHCUngerJMPhillipsKAGoserelin for ovarian protection during breast-cancer adjuvant chemotherapyN Engl J Med20153721092393225738668
   PubMed Web of Science ®Google Scholar
• GerberBvon MinckwitzGStehleHEffect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO studyJ Clin Oncol201129172334234121537042
   PubMed Web of Science ®Google Scholar
• MunsterPNMooreAPIsmail-KhanRRandomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo) adjuvant chemotherapy for breast cancerJ Clin Oncol201230553353822231041
   PubMed Web of Science ®Google Scholar
• SongGGaoHYuanZEffect of leuprolide acetate on ovarian function after cyclophosphamide-doxorubicin-based chemotherapy in premenopausal patients with breast cancer: results from a phase II randomized trialMed Oncol201330366723904400
   PubMed Web of Science ®Google Scholar
• Del MastroLBoniLMichelottiAEffect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trialJAMA2011306326927621771987
   PubMed Web of Science ®Google Scholar
• WangCChenMFuFHuangMGonadotropin-releasing hormone analog cotreatment for the preservation of ovarian function during gonadotoxic chemotherapy for breast cancer: a meta-analysisPloS One201386e6636023805216
   PubMed Web of Science ®Google Scholar
• VitekWSShayneMHoegerKHanYMessingSFungCGonadotropin-releasing hormone agonists for the preservation of ovarian function among women with breast cancer who did not use tamoxifen after chemotherapy: a systematic review and meta-analysisFertil Steril2014102380881525044080
   PubMed Web of Science ®Google Scholar
• ElgindyESibaiHAbdelghaniAMostafaMProtecting ovaries during chemotherapy through gonad suppression: a systematic review and meta-analysisObstet Gynecol2015126118719526241272
   PubMed Web of Science ®Google Scholar
• OremusMWolfsonCPerraultADemersLMomoliFMorideYInterrater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer’s disease drug trialsDement Geriatr Cogn Disord200112323223611244218
   PubMed Web of Science ®Google Scholar
• DerSimonianRLairdNMeta-analysis in clinical trialsControl Clin Trials1986731771883802833
   PubMedGoogle Scholar
• BlumenfeldZHow to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embrya, oocytes, or ovariesOncologist20071291044105417914074
   PubMed Web of Science ®Google Scholar
• BukmanAHeinemanMJOvarian reserve testing and the use of prognostic models in patients with subfertilityHum Reprod Update20017658159011727867
   PubMed Web of Science ®Google Scholar
• AndersonRAThemmenAPAl-QahtaniAGroomeNPCameronDAThe effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancerHum Reprod200621102583259216820385
   PubMed Web of Science ®Google Scholar
• BroekmansFJKweeJHendriksDJMolBWLambalkCBA systematic review of tests predicting ovarian reserve and IVF outcomeHum Reprod Update200612668571816891297
   PubMed Web of Science ®Google Scholar
• BroerSLvan DisseldorpJBroezeKAAdded value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approachHum Reprod Update2013191263623188168
   PubMed Web of Science ®Google Scholar